Sitagliptin + Metformin Xr Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 100/1000 mg
Reference Brands: Janumet XR (US & EU)
Category:
Diabetes
Sitagliptin inhibits DPP-4, prolonging incretin activity to enhance insulin secretion and suppress glucagon release. Metformin decreases hepatic glucose production and improves insulin sensitivity. The XR formulation ensures steady glucose control with reduced gastrointestinal side effects. Together, they offer synergistic action, improved glycemic control, and convenient once-daily dosing for Type 2 diabetes management.
Sitagliptin + Metformin XR Tablets is available in Tablets
and strengths such as 100/1000 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Sitagliptin + Metformin XR Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Sitagliptin + Metformin XR Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Sitagliptin + Metformin XR tablets, approved by the FDA (USA) and regulated by the EMA (EU), are indicated for the management of Type 2 diabetes when monotherapy fails. Brands like Janumet XR offer extended glycemic control with once-daily dosing. These tablets must meet stringent bioequivalence, GMP, and pharmacovigilance standards in both markets. EU guidelines require SmPC-compliant labeling and risk management plans. The combination enhances patient adherence and reduces glucose levels effectively. Pharmatradz.com, a global B2B pharmaceutical marketplace, connects buyers with trusted USFDA and EU-GMP certified manufacturers for bulk procurement of Sitagliptin + Metformin XR and other diabetes treatments.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing